The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth ...

Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

A Rs 15,000 monthly SIP for 5 years at 12 per cent annualised return can create an over Rs 2.07 crore corpus if one lets ...

Earnings statements are a staple of corporate communications, a twice-yearly (or sometimes quarterly) opportunity for a ...

Eli Lilly announced a price reduction for its weight-loss drug Zepbound's vials by $50 or more, adapting to stiff competition ...

Building a massive corpus of Rs 8 crore corpus might seem like a distant dream, but what if you could make it a reality in ...

Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...

Eli Lilly has reduced the price of its weight-loss drug, Zepbound, to combat competition from compounding pharmacies and Novo ...

The Outsourcing Facilities Association, a trade group representing compounders, filed a similar lawsuit in October last year ...

Bill Malley, a Richland pharmacist who joined the U.S. military at 17 in 1943, posed with his dental hygienist at age 97 in ...

Ruben Amorim said on Tuesday that his Manchester United players are taking criticism "personally" and believes it's hampering their ability to perform.